Homburger advised Novo Nordisk on its USD 11 billion acquisition of three manufacturing sites from Novo Holdings. The completion follows the finalization of Novo Holdings’ acquisition of Catalent. The three acquired sites specialized in the sterile
Tags :Philipp Stiegeler
Walder Wyss advised Bank J. Safra Sarasin on the acquisition of 100% of the shares of MIV Asset Management(MIV), a medical technology investment fund advised by Homburger. MIV will maintain its existing investment strategy and
The Kellenberger family has significantly reduced its ownership in Calida Holding through two key transactions: a public buy-back offer and a direct share repurchase. Homburger served as legal advisor to the Kellenberger family, guiding them
The team included partner Andreas Müller, lead associate (pictured) Anna Peter and junior associate Philipp Stiegeler (all Corporate / M&A), associate Valentin Fluor (IP / IT and Data Protection), partner Jürg Frick, associates Stefan
The team also advised on Durfy's CHF 250 m equity investment commitment in the context of the planned CHF 700 m rights offering
Homburger advises Dufry on the planned acquisition of all remaining equity interest in Hudson and the related equity financing
